Found: 33
Select item for more details and to access through your institution.
Liver Regeneration Associated Protein (ALR) Exhibits Antimetastatic Potential in Hepatocellular Carcinoma.
- Published in:
- Molecular Medicine, 2011, v. 17, n. 3/4, p. 221, doi. 10.2119/molmed.2010.00117
- By:
- Publication type:
- Article
The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
- Published in:
- Oncogene, 1999, v. 18, n. 1, p. 9, doi. 10.1038/sj.onc.1202284
- By:
- Publication type:
- Article
Development of a Parenterally Administrable Hydrosol Preparation of the 'Third Generation Platinum Complex' [(±)-1,2-Bis(4-fluorophenyl)ethylenediamine]dichloroplatinum(II). Part 1. Preparation and Studies on the Stability and Antitumor Activity.
- Published in:
- Archiv der Pharmazie, 1995, v. 328, n. 9, p. 645, doi. 10.1002/ardp.19953280904
- By:
- Publication type:
- Article
Evaluation of the Mammary Tumor Inhibiting Properties.
- Published in:
- Archiv der Pharmazie, 1992, v. 325, n. 2, p. 113, doi. 10.1002/ardp.19923250211
- By:
- Publication type:
- Article
Dichloro-[1-(hydroxyphenyl)-2-phenylethylenediamine]platinum(II) Complexes: Testing on the Human Ovarian Cancer Cell Lines NIH: OVCAR 3 and SK OV 3.
- Published in:
- Archiv der Pharmazie, 1992, v. 325, n. 2, p. 93, doi. 10.1002/ardp.19923250208
- By:
- Publication type:
- Article
Tumor Inhibiting [1,2-Bis(fluorophenyl)ethylenediamine]platinum(II) Complexes. Part IV: Biological Evaluation - in vivo Studies on the P 388 Leukemia.
- Published in:
- Archiv der Pharmazie, 1991, v. 324, n. 7, p. 405, doi. 10.1002/ardp.19913240702
- By:
- Publication type:
- Article
Tumor Inhibiting [1,2-Bis(difluorophenyl)ethylenediamine]-dichloroplatinum(II) Complexes, I: Synthesis.
- Published in:
- Archiv der Pharmazie, 1991, v. 324, n. 2, p. 115, doi. 10.1002/ardp.19913240211
- By:
- Publication type:
- Article
Tumor Inhibiting [1,2-Bis(fluorophenyl)ethylenediamine]platinum(II) Complexes, III<sup>1)</sup>: Evaluation of the Mammary Tumor Inhibiting Properties.
- Published in:
- Archiv der Pharmazie, 1990, v. 323, n. 5, p. 301, doi. 10.1002/ardp.19903230509
- By:
- Publication type:
- Article
Tumor Inhibiting [1,2-Bis(fluorophenyl)ethylenediamine]platinum(II) Complexes Part II: Biological Evaluation - in vitro Studies on the P 388 D<sub>1</sub> Leukemia Cell Line.
- Published in:
- Archiv der Pharmazie, 1990, v. 323, n. 3, p. 133, doi. 10.1002/ardp.19903230303
- By:
- Publication type:
- Article
Mammary Tumor Inhibiting Properties of the (S,S)-Configurated [1,2-Bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) Complex.
- Published in:
- Archiv der Pharmazie, 1990, v. 323, n. 2, p. 99, doi. 10.1002/ardp.19903230209
- By:
- Publication type:
- Article
Construction and Validation of a Microprocessor Controlled Extracorporal Circuit in Rats for the Optimization of Isolated Limb Perfusion.
- Published in:
- Archiv der Pharmazie, 2004, v. 337, n. 12, p. 672, doi. 10.1002/ardp.200400917
- By:
- Publication type:
- Article
[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action I: Antitumor Activity Due to the Reduction of the Endogenous Estrogen Level.
- Published in:
- Archiv der Pharmazie, 2004, v. 337, n. 6, p. 335, doi. 10.1002/ardp.200300855
- By:
- Publication type:
- Article
[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action II: Contribution of Drug Inactivation, Cellular Drug Uptake and Sterical Factors in the Drug-Target Interaction to the Antitumor Activity
- Published in:
- Archiv der Pharmazie, 2004, v. 337, n. 6, p. 349, doi. 10.1002/ardp.200300856
- By:
- Publication type:
- Article
Establishment and Characterization of New Murine Breast Cancer Cell Lines.
- Published in:
- Archiv der Pharmazie, 2002, v. 335, n. 2/3, p. 55, doi. 10.1002/1521-4184(200203)335:2/3<55::AID-ARDP55>3.0.CO;2-Y
- By:
- Publication type:
- Article
Does [meso-1,2-bis(2,6-dichloro-4-hydroxy-phenyl) ethylenediamine]dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound
- Published in:
- Archiv der Pharmazie, 2001, v. 334, n. 10, p. 309, doi. 10.1002/1521-4184(200110)334:10<309::AID-ARDP309>3.0.CO;2-8
- By:
- Publication type:
- Article
1-(2,6-Dichloro-4-hydroxyphenyl)-2-phenylethanes - New Biological Response Modifiers for the Therapy of Breast Cancer. Synthesis and Evaluation of Estrogenic/Antiestrogenic Properties.
- Published in:
- Archiv der Pharmazie, 2001, v. 334, n. 4, p. 125, doi. 10.1002/1521-4184(200104)334:4<125::AID-ARDP125>3.0.CO;2-D
- By:
- Publication type:
- Article
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloroplatinum (II) Act on the Hormone-Sensitive, Murine Breast Cancer as a Biological Response Modifier? Part II. Studies on the Influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) on the Specific Immune Defense in MXT-M-3,2 Breast Cancer Bearing Mice
- Published in:
- Archiv der Pharmazie, 2000, v. 333, n. 12, p. 397, doi. 10.1002/1521-4184(200012)333:12<397::AID-ARDP397>3.0.CO;2-F
- By:
- Publication type:
- Article
Does [meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloro-platinum(II) Act as an Immune Response Modifier? Part III: Progressively Growing MXT-M-3,2 Breast Cancer Stimulates the Proliferation of Phagocytes in B6D2F<sub>1</sub> Mice.
- Published in:
- Archiv der Pharmazie, 2000, v. 333, n. 12, p. 404, doi. 10.1002/1521-4184(200012)333:12<404::AID-ARDP404>3.0.CO;2-M
- By:
- Publication type:
- Article
Part 1: The MXT-M-3.2 Breast Cancer Stimulates the Growth of an Identical Second Graft; [Meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) Inhibits this Process.
- Published in:
- Archiv der Pharmazie, 2000, v. 333, n. 2/3, p. 69, doi. 10.1002/(SICI)1521-4184(200002)333:2/3<69::AID-ARDP69>3.0.CO;2-D
- By:
- Publication type:
- Article
[meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]sulfato-platinum(II) - Pharmacokinetic Studies.
- Published in:
- Archiv der Pharmazie, 1999, v. 332, n. 6, p. 195, doi. 10.1002/(SICI)1521-4184(19996)332:6<195::AID-ARDP195>3.0.CO;2-H
- By:
- Publication type:
- Article
[meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a Compound with a Specific Activity on Hormone-Sensitive Breast Cancers - Evidence for a Diethylstilbestrol-Like Mode of Action.
- Published in:
- Archiv der Pharmazie, 1999, v. 332, n. 2, p. 59, doi. 10.1002/(SICI)1521-4184(19993)332:2<59::AID-ARDP59>3.0.CO;2-B
- By:
- Publication type:
- Article
Blockage of CRM1-dependent nuclear export of the adenovirus type 5 early region 1B 55-kDa protein augments oncogenic transformation of primary rat cells.
- Published in:
- Oncogene, 2005, v. 24, n. 1, p. 55, doi. 10.1038/sj.onc.1208170
- By:
- Publication type:
- Article
Targeting Melanoma Metastasis and Immunosuppression with a New Mode of Melanoma Inhibitory Activity (MIA) Protein Inhibition.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0037941
- By:
- Publication type:
- Article
Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice.
- Published in:
- Nature Genetics, 2000, v. 24, n. 2, p. 192, doi. 10.1038/72869
- By:
- Publication type:
- Article
Regulation and function of the atypical cadherin FAT1 in hepatocellular carcinoma.
- Published in:
- Carcinogenesis, 2014, v. 35, n. 6, p. 1, doi. 10.1093/carcin/bgu054
- By:
- Publication type:
- Article
MicroRNA‐622 is a novel mediator of tumorigenicity in melanoma by targeting Kirsten rat sarcoma.
- Published in:
- Pigment Cell & Melanoma Research, 2018, v. 31, n. 5, p. 614, doi. 10.1111/pcmr.12698
- By:
- Publication type:
- Article
Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2008, v. 134, n. 5, p. 597, doi. 10.1007/s00432-007-0323-9
- By:
- Publication type:
- Article
Platinum(II) complexes interfering with testicular steroid biosynthesis: drugs for the therapy of advanced or recurrent prostate cancers? Preclinical studies.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2007, v. 133, n. 3, p. 153, doi. 10.1007/s00432-006-0151-3
- By:
- Publication type:
- Article
Establishment and characterization of the follicular thyroid carcinoma cell line ML-1.
- Published in:
- Journal of Molecular Medicine, 2000, v. 78, n. 2, p. 102, doi. 10.1007/s001090000085
- By:
- Publication type:
- Article
Loss of Chemerin in Rhabdomyosarcoma Cells Polarizes Adjacent Monocytes to an Immunosuppressive Phenotype.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102610
- By:
- Publication type:
- Article
Development of a Neurotensin-Derived 68 Ga-Labeled PET Ligand with High In Vivo Stability for Imaging of NTS 1 Receptor-Expressing Tumors.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4922, doi. 10.3390/cancers14194922
- By:
- Publication type:
- Article
CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity.
- Published in:
- FASEB Journal, 2007, v. 21, n. 2, p. 456, doi. 10.1096/fj.05-4739com
- By:
- Publication type:
- Article
Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma.
- Published in:
- Cancer Science, 2009, v. 100, n. 4, p. 646, doi. 10.1111/j.1349-7006.2009.01087.x
- By:
- Publication type:
- Article